SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-009945
Filing Date
2021-02-17
Accepted
2021-02-17 08:05:43
Documents
12
Period of Report
2021-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea135578-8k_nektartherap.htm   iXBRL 8-K 40586
  Complete submission text file 0001213900-21-009945.txt   215872

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nktr-20210212.xsd EX-101.SCH 3171
3 XBRL LABEL FILE nktr-20210212_lab.xml EX-101.LAB 34582
4 XBRL PRESENTATION FILE nktr-20210212_pre.xml EX-101.PRE 22697
5 EXTRACTED XBRL INSTANCE DOCUMENT ea135578-8k_nektartherap_htm.xml XML 3501
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 21642695
SIC: 2834 Pharmaceutical Preparations